Funds and ETFs Bachem Holding AG

Equities

BANB

CH1176493729

Biotechnology & Medical Research

Market Closed - Swiss Exchange 11:31:30 2024-04-26 am EDT 5-day change 1st Jan Change
81.1 CHF +2.53% Intraday chart for Bachem Holding AG +3.12% +24.77%

ETFs positioned on Bachem Holding AG

Name Weight AuM 1st Jan change Investor Rating
0.04% 6 M€ -.--% -
0.03% 6 M€ -.--%
0.03% 31 M€ +3.50% -
0.02% 10 M€ -3.35% -
0.01% 1,166 M€ +0.26% -
0.01% 607 M€ +0.05% -
0.01% 206 M€ -.--%
0.01% 284 M€ -.--%
0.00% 273 M€ +15.83%
0.00% 7 M€ +0.11% -
0.00% 389 M€ +6.83% -
0.00% 34 M€ +6.71% -
0.00% 34 M€ +2.14% -
0.00% 237 M€ +2.89% -
0.00% 302 M€ +3.80% -
0.00% 39 M€ +3.67% -
0.00% 1 M€ -.--% -
0.00% 29 M€ -3.48% -
0.00% 152 M€ -3.56% -
0.00% 26 M€ -4.26% -
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
6
Last Close Price
81.1 CHF
Average target price
70.8 CHF
Spread / Average Target
-12.70%
Consensus
  1. Stock Market
  2. Equities
  3. BANB Stock
  4. Funds and ETFs Bachem Holding AG